Literature DB >> 1729070

Etiology and diagnosis of pneumonia requiring ICU admission.

P D Potgieter1, J M Hammond.   

Abstract

The spectrum of pathogens and the microbiologic investigations used to obtain a diagnosis in 178 patients with severe pneumonia (88 percent requiring intermittent positive-pressure ventilation) are reviewed. Ninety-five patients had primary pneumonia, 31 had nosocomial pneumonia, 24 were immunocompromised patients, and 28 had aspiration pneumonia. While the spectrum of isolates conformed to the usual patterns for the different types of pneumonia, the incidence of Gram-positive infections (15 percent), predominantly Klebsiella pneumoniae, Staphylococcus aureus, (8 percent), and Legionella pneumophila (5 percent) in primary pneumonia was much higher than in community or general hospital-based studies, and only one case of Mycoplasma pneumoniae was identified. Gram stain of sputum or tracheal aspirate taken on intubation in primary pneumonia was reliably predictive of the causative organisms in both Gram-positive and Gram-negative infections when compared with infections proven by blood culture. Serologic studies were valuable in patients in whom no positive microbiologic diagnosis was evident; however, fiberoptic bronchoscopy contributed minimally to the microbiologic diagnosis in this group of patients. The cause of severe primary pneumonia differs from less severe disease, and this should be recognized when selecting empiric antibiotic therapy.

Entities:  

Mesh:

Year:  1992        PMID: 1729070     DOI: 10.1378/chest.101.1.199

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  The pulmonary physician in critical care 1: pulmonary investigations for acute respiratory failure.

Authors:  J Dakin; M Griffiths
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

Review 3.  The pulmonary physician in critical care . 3: critical care management of community acquired pneumonia.

Authors:  S V Baudouin
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

4.  Acute pneumonia and systemic lupus erythematosus.

Authors:  M V Sun; P J Kaplan
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-01

5.  Clarithromycin in the Treatment of Legionella pneumophila Pneumonia Associated with Multiorgan Failure in a Previously Healthy Patient.

Authors:  L Gallelli; V Gioffrè; G Vero; A Gallelli; F Roccia; S Naty; G Pelaia; A Capano; A Loiacono; G De Sarro; R Maselli
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

6.  Clinical spectrum of ventilator-associated pneumonia caused by methicillin-sensitive Staphylococcus aureus.

Authors:  D Bergmans; M Bonten; C Gaillard; P de Leeuw; F van Tiel; E Stobberingh; S van der Geest
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

7.  Infections in critically ill patients: experience in MICU at a major teaching hospital.

Authors:  N S Dahmash; S C Arora; D F Fayed; M N Chowdhury
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

8.  Clinical utility of a Legionella pneumophila urinary antigen test in a large university teaching hospital.

Authors:  Michel Dionne; Todd Hatchette; Kevin Forward
Journal:  Can J Infect Dis       Date:  2003-03

9.  Non-invasive mechanical ventilation in severe chronic obstructive lung disease and acute respiratory failure: short- and long-term prognosis.

Authors:  M Vitacca; E Clini; F Rubini; S Nava; K Foglio; N Ambrosino
Journal:  Intensive Care Med       Date:  1996-02       Impact factor: 17.440

10.  Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns.

Authors:  Wen-Chien Ko; David L Paterson; Anthanasia J Sagnimeni; Dennis S Hansen; Anne Von Gottberg; Sunita Mohapatra; Jose Maria Casellas; Herman Goossens; Lutfiye Mulazimoglu; Gordon Trenholme; Keith P Klugman; Joseph G McCormack; Victor L Yu
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.